GNH USA

Europe — EMA

Palexia (Tapentadol)

Tapentadol, the active ingredient in Palexia, is an opioid analgesic presented as a strength/form for oral use. It is indicated for the management of moderate to severe acute pain in adult patients.

International sale not permitted. Listed for the domestic market and B2B only.

Request sourcing

1
Pack/s

What is Tapentadol?

Tapentadol, the active ingredient in Palexia, is an opioid analgesic presented as a strength/form for oral use. It is indicated for the management of moderate to severe acute pain in adult patients. GNH USA supplies Palexia as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Palexia as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Tapentadol used for?

Tapentadol is used in the management of pain through its action on the central nervous system.

- Acute postoperative pain: Provides relief of moderate to severe pain following surgery. - Chronic musculoskeletal pain: Helps to manage the persistent pain associated with musculoskeletal conditions.\n- Neuropathic  ​   ​  ​  ​  ​  ​ ​  ​  ​  ​  ​  ​  ​:          …  …  ...  ...  ...  …  …  ...  -  …  …  ...  ...  … …  …  …  …  …  …  

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Tapentadol
Route
Oral Use
Manufacturer
Grünenthal Gmbh
Origin
EU

Related products